*** PLEASE NOTE THIS TALK WILL BE VIA ZOOM ***
Zoom ID is 849 7786 7996 Password 614522 or direct link
Speaker: Dr Clare Hoskins, Reader, School of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK
Title: Nano-assassins for pancreatic cancer
Chair: Dr Amy Holmes, THRF Early Career Fellow, Therapeutics Research Centre, University of South Australia and BHI, TQEH
Speaker biography: Dr Clare Hoskins is a Reader in the School of Pure and Applied Chemistry. She has published more than 50 peer reviewed articles and filed 1 patent. Her research has been supported with over £3M national and international research funding. Clare is the Chair of the Royal Society of Chemistry, Chemical Nanosciences and Nanotechnology Network, the Conference Chair of next years Controlled Release Society Annual Meeting, and she is a committee member of the UK and Ireland Controlled Release Society. Clare has been awarded the Academy of Pharmaceutical Sciences ‘Emerging Scientist’ sponsored by Pfizer, the North Staffordshire Medical Institute Researcher Award and the Strathclyde’s Women in Leadership Award. Clare leads a vibrant interdisciplinary research group working on nanopharmaceutics. The focus of her research is the development of a range of multifunctional nanoparticles and their translation into medical therapies with a special focus on pancreatic cancer.